Francisco Grandas

Summary

Country: Spain

Publications

  1. ncbi Nocturnal problems occurring in Parkinson's disease
    F Grandas
    Department of Neurology, Hospital General Universitario Gregorio Maranon, C Doctor Esquerdo 46, 28007 Madrid, Spain
    Neurology 63:S8-11. 2004
  2. ncbi Treatment of Parkinson's disease in Spain
    Francisco Grandas
    Servicio de Neurologia, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Mov Disord 18:87-9. 2003
  3. ncbi Transient blepharospasm secondary to unilateral striatal infarction
    Francisco Grandas
    Service of Neurology, Hospital General Universitario Gregorio Maranon, C Doctor Esquerdo, 46, 28007 Madrid, Spain
    Mov Disord 19:1100-2. 2004
  4. ncbi Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention
    F Grandas
    Department of Neurology, Hospital Universitario Gregorio Maranon, Madrid, Spain
    Eur J Neurol 14:282-9. 2007
  5. doi Hemiballismus
    Francisco Grandas
    Department of Neurology, Hospital Universitario Gregorio Marañón and Parkinson s Disease and Movement Disorders Unit, Hospital Beata Maria Ana, Madrid, Spain
    Handb Clin Neurol 100:249-60. 2011
  6. doi Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias
    Nuria López-Ariztegui
    Movement Disorders Research Unit, Hospital Universitario Gregorio Maranon, C Doctor Esquerdo 46, Madrid, Spain
    Clin Neuropharmacol 32:321-5. 2009
  7. ncbi Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. The STAR Study Group
    P Martinez-Martin
    Department of Neurology, Hospital Universitario de Getafe, Madrid
    Neurologia 14:338-43. 1999
  8. ncbi [Cardiac valvulopathy and dopamine agonist]
    F Grandas
    Servicio de Neurologia, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Neurologia 22:870-81. 2007
  9. ncbi [Physiopathology of the dyskinesias induced by L-dopa]
    F Grandas
    , , Madrid,
    Rev Neurol 25:S151-6. 1997
  10. doi Risk factors for freezing of gait in Parkinson's disease
    Ana Contreras
    Movement Disorders Research Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    J Neurol Sci 320:66-71. 2012

Collaborators

Detail Information

Publications13

  1. ncbi Nocturnal problems occurring in Parkinson's disease
    F Grandas
    Department of Neurology, Hospital General Universitario Gregorio Maranon, C Doctor Esquerdo 46, 28007 Madrid, Spain
    Neurology 63:S8-11. 2004
    ..This article reviews the clinical characteristics of some nocturnal motor problems that often induce sleep disruption in PD patients...
  2. ncbi Treatment of Parkinson's disease in Spain
    Francisco Grandas
    Servicio de Neurologia, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Mov Disord 18:87-9. 2003
    ....
  3. ncbi Transient blepharospasm secondary to unilateral striatal infarction
    Francisco Grandas
    Service of Neurology, Hospital General Universitario Gregorio Maranon, C Doctor Esquerdo, 46, 28007 Madrid, Spain
    Mov Disord 19:1100-2. 2004
    ..This case emphasizes the role of the nondominant striatum in the pathophysiology of eyelid motor abnormalities...
  4. ncbi Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention
    F Grandas
    Department of Neurology, Hospital Universitario Gregorio Maranon, Madrid, Spain
    Eur J Neurol 14:282-9. 2007
    ..An early adjustment of entacapone and levodopa doses reduces the number of treatment discontinuations during the first months of treatment...
  5. doi Hemiballismus
    Francisco Grandas
    Department of Neurology, Hospital Universitario Gregorio Marañón and Parkinson s Disease and Movement Disorders Unit, Hospital Beata Maria Ana, Madrid, Spain
    Handb Clin Neurol 100:249-60. 2011
    ..Surgical treatment, especially pallidotomy, is a therapeutic option for the minority of patients with severe persistent disabling hemiballism...
  6. doi Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias
    Nuria López-Ariztegui
    Movement Disorders Research Unit, Hospital Universitario Gregorio Maranon, C Doctor Esquerdo 46, Madrid, Spain
    Clin Neuropharmacol 32:321-5. 2009
    ..To study the possible relationship between central levodopa influx and short-term antiparkinsonian and dyskinetic responses to levodopa in patients with Parkinson disease...
  7. ncbi Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. The STAR Study Group
    P Martinez-Martin
    Department of Neurology, Hospital Universitario de Getafe, Madrid
    Neurologia 14:338-43. 1999
    ..However, little is known about the effect of this strategy on the health-related quality of life (QoL)...
  8. ncbi [Cardiac valvulopathy and dopamine agonist]
    F Grandas
    Servicio de Neurologia, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Neurologia 22:870-81. 2007
    ..To assess the possible relationship between treatment with dopamine agonists and cardiac fibrotic valvulopathy in Parkinson's disease, a systematic review of published articles describing this association was performed...
  9. ncbi [Physiopathology of the dyskinesias induced by L-dopa]
    F Grandas
    , , Madrid,
    Rev Neurol 25:S151-6. 1997
    ..Dyskinesias are one of most frequent motor complications of parkinsonian patients on chronic levodopa treatment. This article reviews their clinical characteristics, risk factors, pathophysiology and possible therapeutical approaches...
  10. doi Risk factors for freezing of gait in Parkinson's disease
    Ana Contreras
    Movement Disorders Research Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    J Neurol Sci 320:66-71. 2012
    ..It is not primarily associated with dopamine replacement therapy and may occur early in young patients...
  11. doi Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease
    Beatriz De la Casa-Fages
    Movement Disorders Research Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    J Neurol Sci 312:191-3. 2012
    ..The outcome of postoperative dopamine dysregulation syndrome is poor despite deep brain stimulation adjustments, attempts to reduce the dose of dopaminergic drugs and the addition of quetiapine or antidepressants...
  12. ncbi Levodopa-induced dyskinesias
    Giovanni Fabbrini
    Department of Neurological Sciences University of Rome La Sapienza, Rome, Italy
    Mov Disord 22:1379-89; quiz 1523. 2007
    ..New rating measures to assess severity and disability related to dyskinesia are in the process of development and clinimetric testing...
  13. ncbi Bupropion-induced parkinsonism
    Francisco Grandas
    Mov Disord 22:1830-1. 2007